Incyte
INCY
#975
Rank
S$30.13 B
Marketcap
S$147.87
Share price
-1.07%
Change (1 day)
11.15%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): S$2.75

According to Incyte's latest financial reports the company's current EPS (TTM) is S$2.71. In 2025 the company made an earnings per share (EPS) of S$8.51 an increase over its 2024 EPS that were of S$0.40.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$2.75-67.7%
2025S$8.512029.03%
2024S$0.40-88.39%
2023S$3.4473.38%
2022S$1.99-64.1%
2021S$5.53-408.63%
2020S-$1.79-166.83%
2019S$2.68300%
2018S$0.67-133.33%
2017S-$2.01-378.57%
2016S$0.722700%
2015S$0.02580-106.67%
2014S-$0.39-44.44%
2013S-$0.7050%
2012S-$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$6.77 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-66.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85 1,370.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.42 727.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.34 23.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S-$0.10-103.81%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S-$0.75-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S-$1.08-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S-$0.28-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA